EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficient Long-term CD20-targeted Therapy for Relapsing Lymphoproliferative Bowel Disease in an AID-deficient Patient

Marcel Horning, AID study group, Marco Fischer, Vasil Toskov, Sarah Salou, Gabriella Cericola, Maria Elena Maccari, Christoph Schell, Christine Forster, Ulrike Teufel-Schäfer, Stephan Ehl, Carsten Speckmann

Journal of Clinical Immunology · 12.11.2026 · 46 (1)

DOI: 10.1007/s10875-026-02074-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Immunology, online erschienen am 12.11.2026. Verfasst von Marcel Horning und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology and Oncology, Children's Hospital, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, …. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Freiburg.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Pediatric Hematology and Oncology, Children's Hospital, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of Allergology and Clinical Immunology, Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland.
  • Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Department of General Pediatrics, Adolescent Medicine and Neonatology, Medical Center, Faculty of Medicine, Children's Hospital, University of Freiburg, Freiburg, Germany.

Förderung

  • Universitätsklinikum Freiburg

Zitieren

APA

Horning, M., AID study group, Fischer, M., Toskov, V., Salou, S., Cericola, G., Maccari, M. E., Schell, C., Forster, C., Teufel-Schäfer, U., Ehl, S., & Speckmann, C. (2026). Efficient Long-term CD20-targeted Therapy for Relapsing Lymphoproliferative Bowel Disease in an AID-deficient Patient. Journal of Clinical Immunology, 46(1). https://doi.org/10.1007/s10875-026-02074-2

Vancouver

Horning M, AID study group, Fischer M, Toskov V, Salou S, Cericola G, et al. Efficient Long-term CD20-targeted Therapy for Relapsing Lymphoproliferative Bowel Disease in an AID-deficient Patient. Journal of Clinical Immunology. 2026;46(1). doi:10.1007/s10875-026-02074-2

BibTeX
@article{Horning2026,
  author = {Horning, Marcel and AID study group, AID study group and Fischer, Marco and Toskov, Vasil and Salou, Sarah and Cericola, Gabriella and Maccari, Maria Elena and Schell, Christoph and Forster, Christine and Teufel-Schäfer, Ulrike and Ehl, Stephan and Speckmann, Carsten},
  title = {Efficient Long-term CD20-targeted Therapy for Relapsing Lymphoproliferative Bowel Disease in an AID-deficient Patient},
  journal = {Journal of Clinical Immunology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10875-026-02074-2}
}
Kostenlos starten →